Capital Analysts, LLC
- SEC CIK
- 0001624758
- Latest filing
- Aug 5, 2026
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings
- Shares (Q2 2026)
- 446
- Value
- $26.0K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 446 | $26.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 446 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 446 | $27.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 446 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 446 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 446 | $32.0K | <0.1% | −71−13.7% | Reduced | Holders |
| Q4 2024 | 517 | $34.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 517 | $36.0K | <0.1% | −243−32.0% | Reduced | Holders |
| Q2 2024 | 760 | $63.0K | <0.1% | −135−15.1% | Reduced | Holders |
| Q1 2024 | 895 | $78.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 895 | $86.0K | <0.1% | −105−10.5% | Reduced | Holders |
| Q3 2023 | 1,000 | $88.0K | <0.1% | +121+13.8% | Added | Holders |
| Q2 2023 | 879 | $76.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 879 | $85.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 879 | $91.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 879 | $75.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 879 | $73.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 879 | $68.0K | <0.1% | −65−6.9% | Reduced | Holders |
| Q4 2021 | 944 | $83.0K | <0.1% | +944 | New | Holders |